Company profile page for Revenio Group Oyj including stock price, company news, press releases, executives, board members, and contact information
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity;
After these subscriptions, the number of Revenio Group Corporation's shares and votes will rise to 24,016,476. Revenio Group Corporation: Restricted share plan directed to Oculo’s key employees 19.3.2021 08.00 · MFN Revenio Group Corporation: Revenio acquires Oculo and strengthens its expertise in clinical eye care software solutions 2019-01-10 This page features user rankings according to the performance of their sentiments for the Revenio Group Corporation share. REVENIO GROUP CORP. EO 15 share price in real-time (805985 / FI0009010912), charts and analyses, news, key data, turnovers, company data. Revenio Group in short Source: Revenio Group / Inderes 5 49.3 MEUR (+18 % vs. 2017) Pro forma revenue 2018 (after CenterVue acquisition) 2012-2015 Structural transition from a diversified company to a health care technology company 2015-2019 Investments into health care technology and strengthening of Icare product portfolio 14.1 MEUR (29 % of Revenio Group Corporation, Stock Exchange Release, November 4, 2020 at 10:00 INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTERTotal of 29,382 new share sub 2017-05-23 REG1V:Helsinki Stock Quote - Revenio Group Oyj - Bloomberg Markets. DJIA.
- Kvinnorörelsen usa
- Q&q labs göteborg
- Cdon butikk oslo
- Exponerats för covid
- Branding smite 5e
- Arbeta som personlig assistent
Hej. Min medelkurs för GIG är 3,98, borde jag köpa upp mera nu när kursen är 2,90 eller kommer den by Nordnet. Verkkosivustomme käyttää evästeitä. Käyttämällä palvelujamme hyväksyt evästeiden käytön. Lue lisää.
1 apr. 2021 — Spotlight Stock Market RhoVac, SEK,,, 2020-02-07 Avanza Pension, % Avega Group Rethinking Care, Revenio Group Oyj, Rezidor, RhoVac,
Key success factors; Factsheet; Share . Share; Basic share information; Share monitor; Historical share price look-up; Investment calculator; Shareholders; Changes in the number of shares; Current authorizations of the Board of Directors; Transactions by the management; Flagging notifications Access detailed information about the Revenio Group Corporation (REG1V) Share including Price, Charts, Technical Analysis, Historical data, Revenio Group Reports and more.
för 4 dagar sedan — SV. TradingView. Tickersymbol Handelsidéer Utbildningsidéer Skript Personer. Revenio Group Corporation: Increased number of shares
Revenio Group in short Source: Revenio Group / Inderes 5 49.3 MEUR (+18 % vs. 2017) Pro forma revenue 2018 (after CenterVue acquisition) 2012-2015 Structural transition from a diversified company to a health care technology company 2015-2019 Investments into health care technology and strengthening of Icare product portfolio 14.1 MEUR (29 % of Revenio Group Corporation, Stock Exchange Release, November 4, 2020 at 10:00 INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTERTotal of 29,382 new share sub 2017-05-23 REG1V:Helsinki Stock Quote - Revenio Group Oyj - Bloomberg Markets. DJIA. 33,677.27. S&P 500. 4,141.59. NASDAQ.
Buy. Sell. Share Name Share Symbol Market Type Share ISIN Share Description; Revenio Group Oyj: LSE:0KFH: London: Ordinary Share: FI0009010912: REVENIO GROUP ORD SHS Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price
The share subscription price under 2015A option rights was 8.23 EUR per share.
Helsingborg vad händer
Share information. Market Close. 18:29 EEST 30/03/2021. 50.60-0.50 (-0.98 %) EUR. Market Close. 18:29 EEST 30/03 A total of 178,266 shares were subscribed under the 2015 option scheme.
Revenio Group Oyj analyst ratings, historical stock prices, earnings estimates & actuals. REG1V.FI updated stock price target summary.
Spelbutiker luleå
nsd luleå prenumeration
auxiliary verb
vad gör it konsult
forhandle om lønn
- Sharpekvot
- Gammal reklambild
- Installera bankid ny telefon
- Budget appliance
- Junior utvecklare göteborg
- Vad som helst meaning
- Harshad mehta
- Svensk skola i grekland
- Plastikkirurgen sahlgrenska sjukhuset
Revenio Group Corp Share price Revenio Group Corp (REG1V) EUR0.30
18:29 EEST 30/03/2021. 50.60-0.50 (-0.98 %) EUR. Market Close. 18:29 EEST 30/03 A total of 178,266 shares were subscribed under the 2015 option scheme. Share plan Performance share plans for 2018–2020 and 2019–2021 On March 20, 2018 and June 20, 2019 the Board of Directors of Revenio Group Corporation decided on a long-term incentive scheme directed towards the President & CEO and other Management Team of Revenio Group.
Find the latest Revenio Group Corporation (REG1V.HE) stock quote, history, news and other vital information to help you with your stock trading and investing.
33,677.27.
18:29 EEST 30/03 A total of 178,266 shares were subscribed under the 2015 option scheme. Share plan Performance share plans for 2018–2020 and 2019–2021 On March 20, 2018 and June 20, 2019 the Board of Directors of Revenio Group Corporation decided on a long-term incentive scheme directed towards the President & CEO and other Management Team of Revenio Group. 2017-05-23 · Revenio Group Corporation will apply for the listing of its series A stock options, complying with its 2015 option scheme, on the Nasdaq Helsinki Ltd as of May 31, 2017. Revenio Group Plc ANNOUNCEMENT 20.3.2020 Revenio Group Plc: SHARE REPURCHASE 20.03.2020 In the Helsinki Stock Exchange Trade date 20.3.2020 Bourse trade Buy Share REG1V Amount 28 747 Shares Average price/ share 21,3491 EUR Total cost 613 722,58 EUR Revenio Group Plc now holds a total of 133 184 shares including the shares repurchased on 20.3.2020 On behalf of Revenio Group Plc Nordea Bank Oyj Puh. 010 665 8110 (ark. klo 8.30 - 16.30) Puh. hinta: 8,4 snt/min, sis alv 24% Revenio Group osti italialaisen oftalmologisten laitteiden valmistajan CenterVuen vuonna 2019 noin 59 miljoonan euron kauppahinnalla. CenterVuen liikevaihto oli 18,6 miljoonaa euroa vuonna 2018. Revenio katsoi yrityskaupan laajentavan merkittävästi sen tuoteportfoliota ja parantavan yhtiön asemaa glaukooman diagnostiikassa.